Clinical Trials Research

What Clinical Trials Research does

Clinical Trials Research (CTR), now operating as Headlands Research Sacramento and Headlands Research CTR Lincoln following a 2024-2025 acquisition by Headlands Research, is a private outpatient clinical research site network founded in 1992 by Principal Investigator Jeffrey D. Wayne, MD. The company conducts Phase II-IV clinical trials on behalf of pharmaceutical sponsors and Contract Research Organizations (CROs) from two fully equipped sites in Lincoln and Sacramento, California, staffed by a team of 15+ investigators, coordinators, and recruitment specialists. Therapeutic focus centers on metabolic, cardiovascular, neurological, and gastrointestinal indications — including Type 2 diabetes, high cholesterol, NASH/MASH fatty liver disease, hypertension, heart failure prevention, diabetic peripheral neuropathy, and chronic idiopathic constipation.

CTR's clinical operations are supported by a proprietary customized trial management software handling patient database, visit tracking, study budgets, and financial reporting, alongside extensive cross-EDC experience across Medidata Rave, ClinTrak, Oracle, IBM, Fusion Axiom, Fusion Axiom, and Inform systems. Both sites maintain CLIA-certified on-site laboratories with IATA-certified phlebotomy staff, temperature-controlled drug storage, and emergency equipment. The company holds GCP-certified investigators, IRB-approved pre-screening ICFs across common labs (HbA1c, lipid, eGFR, UACR, ALT, etc.), and HIPAA-compliant data practices, with a 24,000+ subject recruitment database shared with adjoining Lincoln Family Practice.

Revenue is generated exclusively through professional services contracts with pharmaceutical sponsors and CROs, with payment tied to per-protocol budgets and enrollment milestones across approximately 300+ Phase II-IV studies completed since 1992. The go-to-market combines enterprise field sales to sponsors/CROs (feasibility submissions and direct BD) with a full-time internal recruitment department running multi-channel patient acquisition (radio, KCRA Channel 3 TV, social media, direct mail, health fairs, physician referrals). Since 2000, CTR studies have contributed to FDA approval of 200+ medications. Patient participation is free, with study medication, procedures, and lab work provided at no cost and compensation for time and travel.

Name

Clinical Trials Research

Legal name

Clinical Trials Research

Website

https://ctrsites.com

Company type

Private

Founded year

1992

Operating status

Operating

Headcount range

11–50 employees

Short description

Clinical Trials Research (now Headlands Research Sacramento and Lincoln) is a two-site Phase II-IV outpatient clinical research clinic in Northern California conducting 300+ trials since 1992 for pharmaceutical sponsors and CROs across metabolic, cardiovascular, and GI indications.

Ownership category

akta.pro rank

Product category

Clinical Research Services

NAICS

Medical and Diagnostic Laboratories (6215)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Medical Laboratories (8071)

akta.pro primary industry

Clinical Trial Site Operations & Study Coordination (HLAGACAE)

akta.pro secondary industries

Clinical Trial Patient Recruitment & Retention (HLAGACAD), Site Data Management Support (EDC/Source/SDV Readiness) (HLAGACAL), Clinical Trial Financial Management & Payments (Site Budgeting) (HLAGACAM), Point-of-Care & Decentralized Trial Testing Services (HLAGAEAK)

Keywords

• Clinical trial services
• Clinical research site
• Patient recruitment services
• Phase II-IV trials
• Pharmaceutical research

Headquarters

HQ city

Sacramento

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure, Supply Chain

Revenue model

1. Clinical Trial Conduct Services (Sponsors/CROs): CTR generates revenue by conducting Phase II-IV clinical trials on behalf of pharmaceutical sponsors and CROs. Revenue is tied to contract research agreements, study budgets, and performance-based milestones for enrollment and data delivery. The company operates as a privately-owned independent research clinic qualified to conduct Phase I-IV clinical trials.
2. Patient Recruitment Services: Dedicated full-time patient recruitment department identifies and screens eligible participants, adding value to sponsors through rapid enrollment — a key revenue driver in clinical trial contracts.

Pricing tiers

Go-to-market motion3 records

Distribution channels3 records

Marketing channels10 records

Core offering

Clinical Trials Research (now operating as Headlands Research Sacramento and Headlands Research CTR Lincoln) is an independent clinical research site that conducts Phase II-IV outpatient clinical trials on behalf of pharmaceutical sponsors and CROs across therapeutic areas including high cholesterol, type 2 diabetes, fatty liver disease, high blood pressure, cardiovascular disease, diabetic peripheral neuropathy, and chronic idiopathic constipation. The organization operates two CLIA-certified sites in Lincoln and Sacramento, California, with on-site IATA-certified laboratories, temperature-controlled drug storage, and emergency equipment. A dedicated full-time patient recruitment department leverages a 24,000+ subject database and multi-channel community outreach (radio, television, social media, newspaper, direct mail, health fairs) to drive rapid enrollment, while a proprietary customized clinical trial software system manages patient database, visit tracking, study budgets, and financial reporting alongside integrated EDC systems.

Product overview

Clinical Trials Research (now Headlands Research Sacramento and Lincoln) operates as a Phase II-IV clinical trial research site with two locations in the greater Sacramento area of Northern California. The organization offers a unified clinical research service platform that combines core clinical trial execution capabilities with dedicated patient recruitment services. Their therapeutic focus areas include metabolic disorders (Type 2 Diabetes, High Cholesterol, Fatty Liver/NASH, Obesity), cardiovascular conditions (High Blood Pressure, Cardiovascular Disease), neurological complications (Diabetic Peripheral Neuropathy), and gastrointestinal conditions (Chronic Idiopathic Constipation). The company leverages a proprietary customized clinical trial software system for patient database management, visit tracking, and financial reporting, while integrating with major EDC platforms including Medidata Rave, ClinTrak, Oracle, IBM, Fusion Axiom, and Inform for electronic data capture. With over 25 years of experience and more than 300 completed trials, the organization maintains GCP-certified investigators and CLIA-certified laboratory facilities at both sites.

Differentiator

Problem solved

Functional benefit

Products and services

• Clinical Trial Research Services (Phase II-IV) Full-service clinical research site conducting Phase II-IV outpatient clinical trials for pharmaceutical and biotech companies and CROs. The organization runs controlled studies testing investigational medications across multiple therapeutic areas with experienced GCP-certified investigators and clinical staff at two CLIA-certified sites.
• Patient Recruitment Services Dedicated patient recruitment department maintaining a 24,000+ subject database from CTR and Lincoln Family Practice. Services include radio, television, social media, newspaper, direct mail, health fairs, and poster/flyer campaigns to identify and screen eligible study participants for sponsor-contracted trials.
• High Cholesterol Clinical Studies Clinical trials testing investigational medications for patients with high cholesterol on statin therapy. Studies include complimentary lab screenings, study medication, and procedures provided at no cost to qualified participants.
• Type 2 Diabetes Clinical Studies Clinical trials for Type 2 Diabetes patients offering study-related physical exams, EKGs, lab work, and study medication at no cost, with multiple ongoing diabetes studies available at the Sacramento and Lincoln locations.
• Fatty Liver Disease (NASH/MASH) Clinical Studies Clinical trials for fatty liver disease (NASH/MASH) for qualified patients with diabetes and moderate alcohol consumption. Study-related exams, procedures, and lab work are provided at no cost.
• High Blood Pressure (Hypertension) Clinical Studies Clinical trials testing investigational medications for patients with high blood pressure despite being on blood pressure medication; compensation for time and travel may be provided to qualified participants.
• Diabetic Peripheral Neuropathy (DPN) Clinical Studies Clinical studies for individuals suffering from painful diabetic peripheral neuropathy, designed to potentially relieve pain caused by this diabetes complication. Study-related medical care, exams, procedures, and lab work are provided at no cost.
• Cardiovascular Disease Clinical Studies Clinical trials testing the safety and effectiveness of investigational medications for patients with or at risk for cardiovascular disease.
• Chronic Idiopathic Constipation Clinical Studies Clinical trials for adults suffering from chronic constipation. Insurance is not required to participate; physical exams, vital signs, and compensation for time and travel are provided.

Quantifiable outcome

• 300+ Phase II-IV clinical trials completed since 1992
• +5 more outcomes

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration6 records

Feature5 records

Partnerships

Three partnerships are on record, tiered core.

• Lincoln Family PracticecoreStrategic or Co-development PartnerLincoln Family Practice is an adjoining medical practice where Dr. Jeffrey D. Wayne serves as supervising physician. The practice shares a patient database of over 24,000 subjects with CTR, enabling cross-referral of patients for clinical trial participation and continuing medical care.
• Institutional Review Boards (IRBs)coreOthersCTR works with independent Institutional Review Boards that approve and monitor all clinical trial protocols to ensure ethical conduct and participant protection, as required by federal regulation.
• Contract Research Organizations (CROs)coreStrategic or Co-development PartnerCTR has established excellent relationships with numerous CROs as a result of its responsiveness and delivery of high-quality data since 1992. CROs contract CTR to conduct clinical trials on behalf of pharmaceutical sponsors.

Scale indicators7 records

Recent moves5 records

Expansion highlights4 records

Regional players

• Benchmark Research: Multi-site U.S. clinical research network executing Phase II–IV trials across metabolic, cardiovascular, and other indications; comparable to CTR as a competitor in the same SMO segment, though serving different geographies.

Direct peers

• Flourish Research: Multi-site clinical research organization operating dedicated research sites with integrated patient recruitment and central business development; comparable to CTR in therapeutic breadth, SMO business model, and sponsor/CRO target customers.
• Headlands Research: Parent organization of CTR; operates a multi-site clinical research network across the U.S. and Canada. Directly comparable as an SMO executing Phase II–IV trials for sponsors, with overlapping therapeutic areas and identical operational model.
• Accel Research Sites: Network of dedicated clinical research sites operating across the U.S. with therapeutic focus areas including metabolic and cardiovascular indications; directly comparable as a Phase II–IV SMO serving pharma sponsors and CROs.
• Clinvest / Clinvest Research: Privately-held clinical research site network conducting Phase II–IV trials for sponsors across therapeutic areas including diabetes and metabolic disease; closely comparable to CTR in business model, sponsor relationships, and therapeutic mix.

Broad incumbents

• Velocity Clinical Research: One of the largest integrated clinical trial site networks in the U.S., running multi-therapeutic Phase II–IV trials with broad sponsor relationships; comparable to CTR as a multi-site SMO serving pharma and CROs in the same therapeutic areas (metabolic, cardio, GI).
• Parexel (Site Alliance / Patient Access): Large CRO with affiliated site network (Patients Access) that channel sponsor protocols to high-performing partner sites like CTR; adjacent peer as a major customer/funnel for CTR and a buyer of similar site-level research execution services.
• Mayo Clinic Clinical Trials: Large academic medical center conducting a high volume of Phase II–IV outpatient clinical trials for sponsors in metabolic and cardiovascular disease; comparable to CTR as a research-performing clinical site, though at much greater scale and brand.
• Labcorp Clinical Trials / Labcorp Drug Development: Major central lab and CRO that supports Phase II–IV trials with kit/specimen handling and central laboratory services — comparable on the diagnostic testing side of CTR's offering (CLIA labs, IATA-certified phlebotomy) and as a CRO channeling protocols to sites.
• CenExel Clinical Research: National network of clinical research sites conducting Phase I–IV trials across multiple therapeutic areas with dedicated recruitment databases; comparable to CTR as a multi-site SMO competing for the same sponsor and CRO business.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/ctrsites

Compliance6 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Clinical Trials Research